The 2015 adult immunization schedule is similar to last year’s schedule, with one major change, according to the Centers for Disease Control and Pre... More »
The Food and Drug Administration approved the first generic formulation of esomeprazole magnesium delayed-release capsules, the agency announced Jan. ... More »
An updated version of a blood screening assay that detects human immunodeficiency virus type 1 (HIV-1), hepatitis C virus (HCV), and hepatitis B virus... More »
Nearly 40% of a reproductive age women enrolled in Medicaid and nearly 30% of those with private insurance filled an opioid prescription between 2008 ... More »
HYATTSVILLE, MD. – The majority of a Food and Drug Administration advisory panel voted against approval of an orally disintegrating sublingual table... More »
A combination of a cephalosporin and a beta-lactamase inhibitor in an intravenous formulation has been approved for treating complicated intra-abdominal infections and complicated urinary tract...
The Food and Drug Administration has approved a topical formulation of ivermectin for the once-daily topical treatment of inflammatory lesions related to rosacea. The drug will be marketed as...
The Food and Drug Administration has approved the four-drug combination package Viekira Pak for the treatment of hepatitis C virus genotype 1 infection with or without cirrhosis, the agency announced...
Olaparib, a poly ADP-ribose polymerase (PARP) inhibitor, has been approved for treating advanced ovarian cancer associated with defective BRCA genes, the Food and Drug Administration announced on...
Olaparib, a poly ADP-ribose polymerase (PARP) inhibitor, has been approved for treating advanced ovarian cancer associated with defective BRCA genes, the Food and Drug Administration announced on...